A Randomized, Double-Blind, Comparator- and Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602 in Type 2 Diabetic Patients
Clinical trial NCT01280695 · COMPLETED
Trial details
- NCT number
- NCT01280695
- Sponsor
- Metabolic Solutions Development Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2011-06-01
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.